STATE STREET CORP

Holdings History for Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

Symbol: TSHA on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$59,345,462	10,790,084	+3,553,619	+49%	$5.50	Q4 2025
30 Sep 2025	0%	+0%	$23,663,241	7,236,465	+2,098,155	+41%	$3.27	Q3 2025
30 Jun 2025	0%	+0%	$11,869,496	5,138,310	+1,904,798	+59%	$2.31	Q2 2025
31 Mar 2025	0%	-0%	$4,494,582	3,233,512	-3,240,855		$1.39	Q1 2025
31 Dec 2024	0%	+0%	$11,200,655	6,474,367	+3,005,299	+87%	$1.73	Q4 2024
30 Sep 2024	0%	+0%	$6,972,827	3,469,068	+150,647	+4.5%	$2.01	Q3 2024
30 Jun 2024	0%	+0%	$7,433,263	3,318,421	+2,978,901	+877%	$2.24	Q2 2024
31 Mar 2024	0%	+0%	$974,422	339,520	+196,300	+137%	$2.87	Q1 2024
31 Dec 2023	0%	0%	$253,499	143,220	+3,200	+2.3%	$1.77	Q4 2023
30 Sep 2023	0%	+0%	$442,463	140,020	+25,100	+22%	$3.16	Q3 2023
30 Jun 2023	0%	0%	$75,962	114,920	0		$0.66	Q2 2023
31 Mar 2023	0%	0%	$91,660	114,920	0		$0.80	Q1 2023
31 Dec 2022	0%	+0%	$259,719	114,920	+37,500	+48%	$2.26	Q4 2022
30 Sep 2022	0%	0%	$149,000	77,420	0		$1.92	Q3 2022
30 Jun 2022	0%	-0%	$288,000	77,420	-421,794	-84%	$3.72	Q2 2022
31 Mar 2022	0%	+0%	$3,255,000	499,214	+35,045	+7.6%	$6.52	Q1 2022
31 Dec 2021	0%	+0%	$5,408,000	464,169	+111,983	+32%	$11.65	Q4 2021
30 Sep 2021	0%	+0%	$6,558,000	352,186	+33,567	+11%	$18.62	Q3 2021
30 Jun 2021	0%	+0%	$6,755,000	318,619	+196,478	+161%	$21.20	Q2 2021
31 Mar 2021	0%	+0%	$2,479,000	122,141	+12,035	+11%	$20.30	Q1 2021
31 Dec 2020	0%	+0%	$2,922,000	110,106	+110,106	NEW	$26.54	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.